No ownership or control links for DENG KE are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is DENG KE's risk level?

WhiteIntel flags DENG KE as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does DENG KE appear across sources?

DENG KE is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

Dossier

■

DENG KE

Name: DENG KE — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, DENG KE, Company, US

Low

CompanyUS

View network JSON / MCPsample

Fig. 01 — Cross-source signature

/01

At a glance

Dimensions on file

Subsidiaries: 1

/02

Key facts

Risk signal

Low

Risk

DENG KE is a Company registered in US resolved across 1 source in the WhiteIntel corporate-ownership graph.

/03

Ownership & control

Owners / controllers

None in current sources.

Holdings / subsidiaries

DENG KE
- CHINA PHARMA HOLDINGS, INC.· tenpercentowner· via SEC EDGAR

/04

Directorship network

10 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

CHINA PHARMA HOLDINGS, INC.

LIU TAO (CHENGDU)tenpercentowner
LI ZHILINdirector
LI ZHILINtenpercentowner
LI ZHILINofficer
WAUNG FRANKofficer
TSUI HEUNG MEIdirector
TSUI HEUNG MEItenpercentowner
ZHANG YINGWENdirector
DONG BAOWENdirector
BENNETT G MICHAELdirector

/ Community notesFREE

Analyst context the registries don’t carry — corrections, links, open questions on DENG KE. Notes are community-contributed leads, not verified facts.

Loading notes…